CS Professional · Corporate Restructuring, Valuation and Insolvency · Documentation - Merger and Amalgamation
Ganga Pharma Ltd plans to absorb Yamuna Labs Ltd. Before finalising the exchange ratio, Ganga's team reviews Yamuna's contracts, pending litigation, tax assessments and title to properties. What is the main purpose of this exercise in the merger process?
The review is due diligence. Its purpose is to verify the target's legal, financial and commercial position and uncover risks, so that valuation and scheme terms can be set or adjusted. It comes before the scheme is drafted and approved, and does not itself sanction or implement the merger.
- ATo obtain the Tribunal's sanction of the scheme
- BTo verify the target's legal, financial and commercial position so that risks are identified and the terms can be set or adjustedCorrect
- CTo fix the appointed date of the scheme
- DTo allot shares to the shareholders of Yamuna Labs
Explanation
Due diligence is an investigative review of the target before the deal terms are fixed. It identifies liabilities and issues that feed into valuation and the scheme terms. Sanction, appointed date and allotment are separate steps that follow later.
Did you get it right without looking?
One question tells you little. A timed set on Documentation - Merger and Amalgamation shows your real accuracy, how long you take and where you lose marks.
More Documentation - Merger and Amalgamation questions
- Meridian Textiles Ltd, a transferor company, allotted shares in breach of the Companies Act, 2013, and its officers in default were liable f…
- Sunrise Textiles Ltd, a transferor company, merged into Vardhan Mills Ltd under an approved scheme. Before the merger, the officers in defau…
- Meera Industries Ltd's Tribunal has ordered a meeting of equity shareholders to approve a merger scheme. Which of the following about the no…
- Which description correctly captures the scope of Section 240 of the Companies Act, 2013?
- Kaveri Auto Ltd and Narmada Components Ltd propose a merger by absorption. The Tribunal has ordered meetings. Under section 232, which of th…
- Two years after Lakshya Pharma Ltd was amalgamated into Vistara Healthcare Ltd, an inquiry finds that the officers in default of Lakshya had…